In summary, ADE treatment diminished expressions of pro-inflammatory markers in in cellular inflammatory model via targeting Akt/mTOR and JAK2/STAT3 signaling pathways. This evidence concerns the gene STAT3 and acute disseminated encephalomyelitis.